May 26, 2015 / 12:38 PM / 2 years ago

BUZZ-IntelliPharmaCeutics International Inc: Pain drug gets "fast track" status

** Canadian biotech company’s U.S.-listed shares up 21 pct at $3.75 premarket

** Company said U.S. FDA granted its abuse-deterrent pain drug “fast track” status

** Fast track status expedites review of drugs intended to treat serious conditions that have few or no treatment options

** Drug, Rexista Oxycodone XR, is intended for management of pain when an around-the-clock analgesic is needed for extended period of time

** Up to Friday’s close, stock had risen about 37 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below